NCT01891422
- Conditions
- Alpha Mannosidosis, Aspartylglucosaminuria, Beta Mannosidosis, +29 more
- Locations
-
- Greenwood Genetic Center North Charleston, South Carolina, United States
Clinical trial condition
Carbohydrate Metabolism, Inborn Errors
Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.
546 public trials
96 recruiting studies
Carbohydrate Metabolism, Inborn Errors trial results
NCT06022380
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
- Locations
-
- Manchester University NHS Foundation Trust Manchester, Lancashire, United Kingdom
NCT02354651
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Completed
Lamazym Aftercare Study
NCT01908725
- Conditions
- Alpha-Mannosidosis, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +7 more
- Locations
-
- Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9 Copenhagen, Denmark
NCT01908712
- Conditions
- Alpha-Mannosidosis, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +7 more
- Locations
-
- Hôpital Femme Mére Enfant - CHU de Lyon Bron, France
NCT01701154
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Duke University Health System Durham, North Carolina, United States
NCT05798416
- Conditions
- Acute Mountain Sickness, Altitude Sickness, Carbohydrate Metabolism, Inborn Errors, +18 more
- Locations
-
- The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
NCT03893240
- Conditions
- Acid Maltase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +17 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- University of California Irvine Health Orange, California, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- University of Minnesota Medical School Minneapolis, Minnesota, United States
Completed
Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.
NCT01898364
- Conditions
- Acid Maltase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +15 more
- Locations
-
- Investigational Site Number 840006 Phoenix, Arizona, United States
- Investigational Site Number 840010 Jacksonville, Florida, United States
- Investigational Site Number 840001 Kansas City, Kansas, United States
- Investigational Site Number 840008 St Louis, Missouri, United States
NCT02746718
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- CHU d'Angers Angers, France
- Centre hospitalier d'Argenteuil Argenteuil, France
- CHU de Brest Brest, France
- CH d'Escartons Briançon, France
Related conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (546)
- Nutritional and Metabolic Diseases (546)
- Metabolic Diseases (534)
- Metabolism, Inborn Errors (534)
- Genetic Diseases, Inborn (525)
- Lysosomal Storage Diseases (320)
- Nervous System Diseases (236)
- Skin and Connective Tissue Diseases (236)